GSA Capital Partners’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.53M	Sell	103,467 -28,481	-22%	-$416K	0.1%	271
2025 Q4	$2.1M	Buy	131,948 +120,484	+1,051%	+$1.71M	0.18%	70
2025 Q3	$127K	Sell	11,464 -267,954	-96%	-$2.93M	0.01%	1502
2025 Q2	$2.37M	Buy	279,418 +190,507	+214%	+$1.53M	0.17%	85
2025 Q1	$715K	Buy	88,911 +77,153	+656%	+$625K	0.06%	553
2024 Q4	$106K	Sell	11,758 -113,887	-91%	-$929K	0.01%	1507
2024 Q3	$921K	Sell	125,645 -102,373	-45%	-$635K	0.07%	522
2024 Q2	$1.3M	Sell	228,018 -121,186	-35%	-$638K	0.09%	342
2024 Q1	$1.75M	Buy	349,204 +231,260	+196%	+$1.57M	0.14%	158
2023 Q4	$1.06M	Buy	+117,944	New	+$971K	0.09%	360
2023 Q3	–	Sell	-168,595	Closed	-$1.63M	–	1488
2023 Q2	$1.63M	Buy	+168,595	New	+$1.75M	0.16%	113
2021 Q4	–	Sell	-22,904	Closed	-$507K	–	1404
2021 Q3	$507K	Buy	+22,904	New	+$363K	0.05%	687